Article
Consequences of CYP2D6 Copy-Number Variation for Pharmacogenomics in Psychiatry
20 Jun 2019
Abstract excerpt
Pharmacogenomics represents a potentially powerful enhancement to the current standard of care for psychiatric patients. However, a variety of biological and technical challenges must be addressed in order to provide adequate clinical decision support for personalized prescribing and dosing based on genomic data. This is particularly true in the case of CYP2D6, a key drug metabolizing gene, which not only harbors...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
